Characterization of neoplastic and normal human breast tissues with in vivo 1H MR spectroscopy

Journal of Magnetic Resonance Imaging

Volumn 10, Issue 2, 1999, Pages 159-164

  Kvistad, Kjell A ^a   Bakken, Inger J ^b   Gribbestad, Ingrid S ^b   Ehrnholm, Benny ^a   Lundgren, Steinar ^a   Fjøsne, Hans E ^a   Haraldseth, Olav ^c  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b SINTEF   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Breast neoplasms; Metabolites; Proton magnetic resonance spectroscopy

Indexed keywords

CHOLINE DERIVATIVE; LIPID;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; BREAST FEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LACTATION; LIPID METABOLISM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TISSUE CHARACTERIZATION; TISSUE METABOLISM;

ADULT; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA; CHOLINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LACTATION; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; MILK, HUMAN; REFERENCE VALUES;

EID: 0032800756     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199908)10:2<159::AID-JMRI8>3.0.CO;2-0     Document Type: Article

References (28)

1. Robinson SP, Barton SJ, McSheeny PMJ, Griffiths JR. Nuclear magnetic resonance spectroscopy of cancer. Br J Radiol 1997;70:60-69.
2. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions - characterization with proton MR spectroscopy. Radiology 1998;209:269-275.
3. Leach MO. Introduction to in vivo MRS of cancer - new perspectives and open problems. Anticancer Res 1996;16:1503-1514.
4. Mackinnon WB, Barry PA, Malych PL, et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997;204: 661-666.
5. Gribbestad IS, Fjøsne HE, Haugen OA, et al. In vitro proton NMR spectroscopy of extracts from human breast tumor and non-involved breast tissue. Anticancer Res 1993;13:1973-1980.
6. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non-involved breast tissue. NMR Biomed 1994;7:181-194.
7. 31P MR spectroscopy at 1.5 T. Radiology 1988;169: 615-620.
8. Merchant TE. MR spectroscopy of the breast. MRI Clin North Am 1994;4:691-703.
9. 31P magnetic resonance spectroscopy for monitoring treatment response in breast cancer. Lancet 1989;1:1326-1327.
10. Kim JK, Park SH. In vivo differential diagnosis between malignant and benign human breast diseases using localized PRESS proton magnetic resonance spectroscopy (abstract). In: Proceedings from the Sixth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Sydney, 1998. p 941
11. Cecil K, Roebuck J, Bolinger L, et al. Evaluation of suspicious breast masses with MR spectroscopy (abstract). In: Proceedings from the Sixth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Sydney, 1998. p 942
12. Gribbestad IS, Singstad Eng TE, Nilsen G, et al. In vivo proton MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998;8:1191-1197.
13. Stelling CB. MR imaging of the breast for cancer evaluation. Radiol Clin North Am 1995;33:1187-1204.
14. Bone B, Pentek Z, Perbeck L, Veress B. Diagnostic accuracy of mammography and contrast enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol 1997;38:489-496.
15. Harms SE, Flamig DP, Hesley KL, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993;187:493-501.
16. Heywang-Köbrunner SH. Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 1994;29:94-104.
17. Ting Y-LT, Sherr D, Degani H. Variations in energy and phospho-lipid metabolism in normal and cancer human mammary epithelial cells. Anticancer Res 1996;16:1381-1388.
18. 1H MRS - correlation with histopathology. Magn Reson Med 1993;30:525-533.
19. Roby C, Martin J-P, Bligny R, Douce R. Biochemical changes during sucrose deprivation in higher plant cells. J Biol Chem 1987;262: 5000-5007.
20. Sternberg SS. Pregnancy and lactation. In: Sternberg SS, ed. Histology for pathologists. New York: Lippincott-Raven; 1997. p 79-81.
21. Battersby S, Anderson TJ. Proliferative and secretory activity in the pregnant and lactating human breast. Virchovs Archiv A Pathol Anat 1988;413:189-196.
22. Mountford CE, Mackinnon WB, Russell P, Rutter A, Delikatny EJ. Human cancers detected by proton MRS and chemical shift imaging ex vivo. Anticancer Res 1996;16:1521-1532.
23. Le Moyec L, Tatoud R, Eugene M, et al. Cell and membrane lipid analysis by proton magnetic resonance spectroscopy in five breast cancer cell lines. Br J Cancer 1992;66:623-628.
24. 1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast. Magn Reson Med 1997;37:222-225.
25. 1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration (abstract). In: Proceedings from the Sixth Scientific Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine, Sydney, 1998. p 1618
26. Segrest JP, Albers JJ. Structure of plasma lipoproteins. In: Colowick SP, Kappler F, eds. Plasma lipoproteins. Orlando, FL: Academic Press; 1986. p 482-489.
27. Smith ICP, Princz EJ, Saunders JK. Magnetic resonance spectroscopy in cancer research. J Can Assoc Radiol 1990;41:32-38.
28. Holmes KT, Mountford CE. Identification of triglyceride in malignant cells. J Magn Reson 1991;93:407-409.